New Treatments Approved for Early and Metastatic Breast Cancer
Aug 4, 2025 · Kisqali: Two combinations approved for treating high-risk, early-stage HR-positive breast cancer. Datroway: Approved for certain metastatic breast cancers. Itovebi: Approved as …
Treatment of Stage IV (Metastatic) Breast Cancer
Treatment of Stage IV (Metastatic) Breast Cancer Stage IV cancers have spread (metastasized) beyond the breast and nearby lymph nodes to other parts of the body. When breast cancer …
Overview of the approach to metastatic breast cancer
Feb 7, 2025 · INTRODUCTION Although metastatic breast cancer (MBC) is unlikely to be cured, meaningful improvements in survival have been seen, coincident with the introduction of …
Plan Your HR+/HER2- MBC Treatment: Key Questions for Your …
2 days ago · Navigate HR+/HER2- metastatic breast cancer treatment by knowing which questions to ask your doctor about progression, next therapies, clinical trials, and quality of life.
ASCO 2025 Metastatic Breast Cancer Updates | Breast Cancer …
Jun 19, 2025 · Investigators presented several potentially practice-changing treatment advances for these patients At the annual meeting of the American Society of Clinical Oncology (ASCO), …
Metastatic Breast Cancer: Symptoms, Treatment & Prognosis
Metastatic breast cancer, also called advanced breast cancer or Stage IV breast cancer, is cancer that’s spread (metastasized) from your breast to other areas of your body. Healthcare …
Metastatic Breast Cancer - What You Need To Know | Susan G.
The MBC Impact Series provides people living with metastatic breast cancer and their loved ones with webinars to gather information and discover practical resources to help make decisions …
Advancing Treatment After CDK4/6 Inhibitor Progression in …
1 day ago · The efficacy of contemporary cancer treatments can be attributed to novel targeted and immunotherapeutic agents capable of selectively targeting cancer cells, such as CDK4/6 …
TUKYSA Added to First-Line Maintenance Therapy Extends Median ...
1 day ago · TUKYSA is approved in combination with trastuzumab and capecitabine to treat adults with HER2-positive advanced unresectable or metastatic breast cancer, including …
Tucatinib Plus Trastuzumab/Pertuzumab Prolongs PFS in HER2 …
1 day ago · As such, there is an unmet need for developing more effective first-line maintenance treatments in HER2-positive metastatic breast cancer.